ProMIS™ Neurosciences, Inc.

ProMIS™ Neurosciences, Inc.

Biotechnology Research United States 20 employees
Employees
20
Contacts
1
Emails
1
Phones
1

ProMIS™ Neurosciences, Inc. Overview

Headquarters
United States
Phone Number
Available in AeroLeads
Industry
Biotechnology Research
Employees
20
Founded
2015
Funding
6.7M
Company Email
Available in AeroLeads
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

About ProMIS™ Neurosciences, Inc.

ProMIS Neurosciences is a clinical-stage biotechnology company committed to the discovery and development of therapeutic antibodies selective for toxic oligomers associated with the development and progression of neurodegenerative and other misfolded protein diseases. The Company’s proprietary target discovery engine, EpiSelect™, predicts novel targets known as Disease Specific Epitopes (DSEs) on the molecular surface of misfolded proteins that cause neurodegenerative and other misfolded protein diseases, including Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD), multiple system atrophy (MSA), and Parkinson’s Disease (PD). ProMIS has offices in Cambridge, Massachusetts (USA) and Toronto, Ontario (CAN).

ProMIS™ Neurosciences, Inc. Contact Details

People in AeroLeads
4
With contact data
1
Email contacts
1
25.0% coverage
Phone contacts
1
25.0% coverage

ProMIS™ Neurosciences, Inc. Org Chart

Sample employees and titles
Name Title Contact
Richard Gregory Biotechnology R&D
Email Phone
Randall Pinchuk Head of Business Development at Promis
View
Daniel Geffken Founder and Managing Director
View
Beibei Zhao Director, Research Programs at Promis™
View

Employees by Management Level

Executive 2 profiles
Individual contributor 2 profiles
VP / Head 1 profile
Director 1 profile

Department Contact Coverage

Department Contacts Email Phone
Executive 1 1 1
Finance 1 1 0

Compare Similar Companies to ProMIS™ Neurosciences, Inc.